China Yct International Group, Inc. Receivables Turnover Ratio (CYIG), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
China Yct International Group, Inc.  (CYIG)
 

China Yct International Group Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


China Yct International Group, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 359.94, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2019. Average collection period, for China Yct International Group's accounts receivable remained unchanged at 1 days, in the Dec 31 2018 quarter.

If we take a look into Healthcare sector 198 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2018 from 35 to 1969.

What is Receivable Turnover Ratio?
What is China Yct International Group, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYIG Receivables Turnover Ratio (Dec 31 2018)
III. Quarter		 (Sep 30 2018)
II. Quarter		 (Jun 30 2018)
I. Quarter		 (Mar 31 2018)
IV. Quarter		 (Dec 31 2017)
III. Quarter
Y / Y Receivable Change -13.77 % - 476.74 % -84.62 % -58.56 %
Y / Y Revenue Change 13.27 % 34.75 % 21.91 % -20.28 % 21.45 %
Receivable Turnover Ratio (TTM) 359.94 337.52 366.8 580.37 196.58
CYIG's Total Ranking # 1969 # 35 # 40 # 1965 # 39
Accounts Receivable average collection period days 1 1 1 1 2
Seq. Receivable Change 48.16 % -66.53 % 108.99 % -16.79 % -
Seq. Revenue Change 4.33 % -10.55 % 24.86 % -2.8 % 24.12 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 199
Overall Market # 1969

Receivable Turnover Ratio Statistics
High Average Low
0.73 0.44 -0.41
(Jun 30 2017)  





CYIG Company Profile • Back to CYIG Efficiency Comparisons • Compare CYIG Receivables Turnover Ratio to its Competitors

Financial Statements
China Yct International Group's Accounts Receivable $ 0 Millions Visit CYIG's Balance sheet
China Yct International Group's Sales TTM $ 76 Millions Visit CYIG's Income Statement
Sources of CYIG's Revenues Visit CYIG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYIG's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CYIG's Growth Rates CYIG's Roa CYIG's Inventory Turnover Ratio CYIG's Dividend Comparisons
CYIG's Profitability Ratios CYIG's Roi CYIG's Asset Turnover Ratio CYIG's Dividend Growth
CYIG's Valuation Ratios CYIG's Roe CYIG's Financial Strength Ratios CYIG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Receivable at quarter ending Dec 31 2018
Principia Biopharma Inc   731.61 $ 69.137  Millions$ 0.095  Millions
Paratek Pharmaceuticals Inc   518.70 $ 17.117  Millions$ 0.033  Millions
China Yct International Group, Inc.  359.94 $ 75.798  Millions$ 0.211  Millions
Icon Plc  292.02 $ 2,595.777  Millions$ 8.889  Millions
Correvio Pharma Corp   281.12 $ 28.674  Millions$ 0.102  Millions
Siga Technologies Inc  276.90 $ 477.053  Millions$ 1.723  Millions
Arrowhead Pharmaceuticals Inc   275.74 $ 47.290  Millions$ 0.172  Millions
Zymeworks Inc   220.22 $ 53.019  Millions$ 0.241  Millions
Scorpius Holdings inc   199.05 $ 5.794  Millions$ 0.029  Millions
Qiagen N v   162.01 $ 1,501.848  Millions$ 9.270  Millions
U s Stem Cell Inc   154.18 $ 6.701  Millions$ 0.043  Millions
Nymox Pharmaceutical Corporation  149.50 $ 0.299  Millions$ 0.002  Millions
Concert Pharmaceuticals Inc   134.68 $ 10.505  Millions$ 0.078  Millions
Reliv International Inc  133.87 $ 36.116  Millions$ 0.270  Millions
Lifevantage Corp  111.56 $ 218.371  Millions$ 1.958  Millions
Editas Medicine Inc   93.52 $ 31.937  Millions$ 0.342  Millions
United Cannabis Corp  88.25 $ 7.245  Millions$ 0.082  Millions
Innovage Holding Corp   85.61 $ 23.990  Millions$ 0.280  Millions

Date modified: 2026-09-08T15:09:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.